FDA Inspection 1027564 — Nicolas Falvo, MD

Nicolas Falvo, MD — FEI 3013606140

The FDA completed an inspection of Nicolas Falvo, MD on Sep 14, 2017 in Dijon. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 14, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dijon (France)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.